Blog Archives

Post-COVID 19 Dementia Increasing Worldwide

3/10/2022

COVID ups risks of dementia, cognitive impairment, and decline in older survivorsSadly and not surprisingly, the science media is reporting that the neurological impact of covid 19 is showing increased levels of cognitive decline worldwide. Older adults are having to cope with damage to their lungs and central nervous system. The study noted that the telephone survey measures used were limited in identifying more specific challenges and likely underestimate the size of the problem due to having excluded subjects with any family history of dementia. The global dementia care burden is likely to be greater as a result of the COVID-19 pandemic and so there is even greater need to rapid intervention now that can be easily, safely and cost effectively deployed. Researchers and clinicians at Quietmind Foundation, Neuronic Devices Ltd (Neuronic.online), Baylor Research Institute and the Biophotonic and Neuroimaging Lab•UTexas-Arlington are collaborating to show the effectiveness of self-administered, transcranial infrared light-based therapy to reduce dementia's cognitive and behavioral symptoms.

The Neuradiant 1070 4Q technology that's being released this month by Neuronic Devices Ltd. (see Neuronic.online) is a resource that can address the debilitating impact of COVID 19 on the brain by increasing cortical perfusion and ATP production by stimulating cytochrome c oxidase and improving blood vessel flexibility. In addition, the new independent 4 -quadrant control of pulse frequency allows for renormalization of dysregulated brain network connectivity using the light pulsations to directly changes in EEG activity.

https://arstechnica.com/science/2022/03/covid-ups-risks-of-dementia-cognitive-impairment-and-decline-in-older-survivors/

March 04th, 2022

3/4/2022

Mental disorders in early life are associated with a significantly increased risk of dementia in later years.
Results of a large, longitudinal, population-based study show that individuals hospitalized for a mental health disorder had a fourfold increased relative risk (RR) for developing dementia compared to those who were not hospitalized with a mental illness. This should come as no surprise to psychotherapists and those involved with treating individuals with trauma in their history. Researchers have already reported on the increased incidence of early onset dementia with any history of head trauma and other studies have clearly correlated the exhibiting of violent behavior with the degree of diagnosable brain trauma a person has sustained.

We must become evermore cognizant of the need to have the differential diagnosis for the entire range of psychiatric and behavioral disorders across the lifespan include a neurotrauma/biophysical/toxicological trauma component.

Quietmind has evolved it's evaluation protocol according to this tripartite framework, wherein we employ functional medicine to determine the contribution of mold and other neurotoxins, bacterial and viral infections, genetic predispositions and lifestyle factors. That data is combined with individual Quantitative EEG neurophysiological, systems-oriented psychological and neuropsychiatric assessments.

Article click here: www.medscape.com/

Mental Illness Tied to Increased Dementia Risk

3/4/2022

Batya Swift Yasgur, MA, LSW March 02, 2022
www.medscape.com/

This article increases the clarity as to how severe emotional stress and dysregulation contribute to the development of neurodegenerative disorders like Alzheimer's, and Parkinson's disease. We have to come to see how mind and body work together to enhance or destroy our capacity for health and well being. Anyone who has been hospitalized for psychiatric illness is at a 4 fold greater risk of developing a neurodegenerative disorder than those who have not been hospitalized.
Greater attention and effort needs to be placed toward prevention and reducing hospitalization for people experiencing emotional crises.